-
Signature
-
/s/ Andrew Jackson
-
Issuer symbol
-
CLDI
-
Transactions as of
-
21 Aug 2025
-
Net transactions value
-
+$5,000
-
Form type
-
4
-
Filing time
-
25 Aug 2025, 20:47:36 UTC
Quoteable Key Fact
"Andrew C. Jackson filed Form 4 for Calidi Biotherapeutics, Inc. (CLDI) on 25 Aug 2025."
Quick Takeaways
- This page summarizes Andrew C. Jackson's Form 4 filing for Calidi Biotherapeutics, Inc. (CLDI).
- 2 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 25 Aug 2025, 20:47.
What Changed
- Previous filing in this sequence was filed on 20 Jun 2024.
- Current net transaction value: +$5,000.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Jackson Andrew C. |
Chief Financial Officer |
C/O CALIDI BIOTHERAPEUTICS, INC., 4475 EXECUTIVE DRIVE, SUITE 200, SAN DIEGO, |
/s/ Andrew Jackson |
25 Aug 2025 |
0001636738 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CLDI |
Common Stock |
Purchase |
$5,000 |
+2,500 |
|
$2.00* |
2,500 |
21 Aug 2025 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CLDI |
Warrant (right to buy) |
Purchase |
|
+2,500 |
|
|
2,500 |
21 Aug 2025 |
Common stock |
2,500 |
$2.00 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses: